Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 27.12% | -76.50% | -16.38% | 60.91% | -206.81% |
| Total Depreciation and Amortization | 10.45% | -0.05% | 0.20% | 1.16% | 1,966.67% |
| Total Amortization of Deferred Charges | 56.92% | -58.18% | 7,916.97% | -81.63% | -- |
| Total Other Non-Cash Items | -53.94% | 331.51% | -440.96% | -91.00% | -- |
| Change in Net Operating Assets | -127.97% | -135.16% | 46.03% | 113.45% | -291.93% |
| Cash from Operations | 12.41% | 20.18% | -19.07% | 51.43% | -156.16% |
| Capital Expenditure | 71.00% | -1,900.00% | 84.62% | 67.98% | -109.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 213.13% |
| Cash from Investing | 71.00% | -1,900.00% | 84.62% | -101.12% | 207.37% |
| Total Debt Issued | -- | -100.00% | 358.40% | -69.33% | 476.92% |
| Total Debt Repaid | -340.00% | 93.19% | -229.37% | 84.46% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -340.00% | -100.40% | 369.26% | -66.60% | 388.60% |
| Foreign Exchange rate Adjustments | 202.42% | -3,486.67% | -475.00% | 110.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.28% | -147.34% | 828.22% | -164.62% | 162.14% |
